Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1967 Dec;46(12):2012–2020. doi: 10.1172/JCI105690

Tyrosine Metabolism in Patients with Liver Disease*

Robert J Levine 1,2, Harold O Conn 1,2
PMCID: PMC292953  PMID: 6074004

Abstract

Plasma levels of tyrosine were assayed in the fasting state and after oral administration of either tyrosine (tyrosine tolerance test) or phenylalanine (phenlyalanine conversion test) in normal subjects and in patients with hepatitis, biliary obstruction, or cirrhosis. Fasting tyrosine levels tended to be slightly increased in patients with hepatitis and biliary obstruction and markedly increased in patients with cirrhosis.

Tyrosine tolerance tests in patients with cirrhosis were characterized by larger than normal increments in tyrosine levels and by delayed returns toward fasting levels.

The results of phenylalanine conversion tests were abnormal in approximately one-half of patients with either hepatitis or biliary obstruction and four-fifths of patients with cirrhosis. Abnormalities were characterized by elevated fasting plasma tyrosine levels, or small and delayed increments in tyrosine levels, or both. Abnormal phenylalanine conversion test results in patients with cirrhosis did not correlate closely with any clinical feature of cirrhosis or with the results of any standard liver function test; there was positive correlation only with abnormal ammonia tolerance, a test of portalsystemic shunting. Tests of tyrosine metabolism do not appear to be useful for routine clinical assessment of liver function. Tyrosine tolerance tests and phenylalanine conversion tests done for purposes of diagnosis of other diseases may yield misleading results in patients with liver disease.

Full text

PDF
2012

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CLARK G. M., EISEMAN B., LINDEMAN G. M. Clinical evaluation of the ammonium citrate tolerance test for determining the patency of a portacaval shunt. J Lab Clin Med. 1956 Oct;48(4):579–588. [PubMed] [Google Scholar]
  2. CONN H. O. Ammonia tolerance as an index of portal-systemic collateral circulation in cirrhosis. Gastroenterology. 1961 Aug;41:97–106. [PubMed] [Google Scholar]
  3. CONN H. O. Ammonia tolerance in liver disease. J Lab Clin Med. 1960 Jun;55:855–871. [PubMed] [Google Scholar]
  4. Conn H. O. Ammonia tolerance in the diagnosis of esophageal varices. A comparison of endoscopic, radiologic, and biochemical techniques. J Lab Clin Med. 1967 Sep;70(3):442–451. [PubMed] [Google Scholar]
  5. EFRON M. L. AMINOACIDURIA. N Engl J Med. 1965 May 20;272:1058–CONTD. doi: 10.1056/NEJM196505202722006. [DOI] [PubMed] [Google Scholar]
  6. GOODFRIEND T. L., KAUFMAN S. Phenylalanine metabolism and folic acid antagonists. J Clin Invest. 1961 Sep;40:1743–1750. doi: 10.1172/JCI104397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HSIA D. Y. Y. Phenylketonuria: the phenylalanine-tyrosine ratio in the detection of the heterozygous carrier. J Ment Defic Res. 1958 Jun;2(1):8–16. doi: 10.1111/j.1365-2788.1958.tb00380.x. [DOI] [PubMed] [Google Scholar]
  8. JERVIS G. A. Detection of heterozygotes for phenylketonuria. Clin Chim Acta. 1960 Jul;5:471–476. doi: 10.1016/0009-8981(60)90054-1. [DOI] [PubMed] [Google Scholar]
  9. LEVINE R. J., LOVENBERG W., SJOERDSMA A. HYDROXYLATION OF TRYPTOPHAN AND PHENYLALANINE IN NEOPLASTIC MAST CELLS OF THE MOUSE. Biochem Pharmacol. 1964 Sep;13:1283–1290. doi: 10.1016/0006-2952(64)90229-1. [DOI] [PubMed] [Google Scholar]
  10. LEVINE R. J., NIRENBERG P. Z., UDENFRIEND S., SJOERDSMA A. URINARY EXCRETION OF PHENETHYLAMINE AND TYRAMINE IN NORMAL SUBJECTS AND HETEROZYGOUS CARRIERS OF PHENYLKETONURIA. Life Sci. 1964 Jun;3:651–656. doi: 10.1016/0024-3205(64)90179-1. [DOI] [PubMed] [Google Scholar]
  11. LEVINE R. J., OATES J. A., VENDSALU A., SJOERDSMA A. Studies on the metabolism of aromatic amines in relation to altered thyroid function in man. J Clin Endocrinol Metab. 1962 Dec;22:1242–1250. doi: 10.1210/jcem-22-12-1242. [DOI] [PubMed] [Google Scholar]
  12. MCDERMOTT W. V., Jr, HUSTON C. J. THE ORAL AMMONIUM TOLERANCE TEST AS AID IN THE INVESTIGATION OF SUSPECTED ESOPHAGO-GASTRIC VARICES. Ann Surg. 1963 Nov;158:820–826. doi: 10.1097/00000658-196311000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Malamos B., Miras C. J., Karli-Samouilidou J. N., Koutras D. A. The serumtyrosine level as an index of thyroid function. J Endocrinol. 1966 Jul;35(3):223–228. doi: 10.1677/joe.0.0350223. [DOI] [PubMed] [Google Scholar]
  14. RIVLIN R. S., MELMON K. L., SJOERDSMA A. AN ORAL TYROSINE TOLERANCE TEST IN THYROTOXICOSIS AND MYXEDEMA. N Engl J Med. 1965 Jun 3;272:1143–1148. doi: 10.1056/NEJM196506032722202. [DOI] [PubMed] [Google Scholar]
  15. STAHL J. Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance. Ann Intern Med. 1963 Jan;58:1–24. doi: 10.7326/0003-4819-58-1-1. [DOI] [PubMed] [Google Scholar]
  16. WAALKES T. P., UDENFRIEND S. A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med. 1957 Nov;50(5):733–736. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES